Does Hip Strength Impact Active Females Rate of Pelvic Floor Dysfunction? The Primary Goal of This Research is to Collect Data on Hip Strength for Active Females and Assess if There is a Relationship Between Hip Strength and Pelvic Floor Dysfunction (PFD).
1 other identifier
observational
55
1 country
1
Brief Summary
The primary goal of this research is to collect data on hip strength for active females and assess if there is a relationship between hip strength and pelvic floor dysfunction (PFD). The participants will fill out a REDCap questionnaire that includes informed consent, demographics, injury history, history of PFD and/or hip pain, characteristics of physical activity and/or sport(s), knowledge of pelvic floor musculature, and questions regarding the correlation between PFD and performance. Additionally, Patient Reported Outcomes Measurement Information System (PROMIS) surveys assessing anxiety and depression will be included. After completing the questionnaires, a one time hip strength assessment will be performed in four directions on each hip and the evaluator will be blinded to their results. Foster et al researched hip and pelvic floor strength in a different patient population (Urgency and Frequency prominent lower urinary tract symptoms) in 2021 with 18-60 year olds and did not have a classification for level of physical activity. This research group found that there was a reduction in hip external rotation and abduction strength compared to case controls. To this point, there has not been any research assessing the relationship between hip strength and relaxing versus nonrelaxing pelvic floor dysfunction and controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2025
CompletedFirst Submitted
Initial submission to the registry
July 30, 2025
CompletedFirst Posted
Study publicly available on registry
August 13, 2025
CompletedAugust 13, 2025
August 1, 2025
4 months
July 30, 2025
August 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Inline Tension Dynamometer: Hip Strength Assessment
The hip strength assessment will be performed in person and will include four strength assessments (hip abduction, hip adduction, hip external rotation and hip internal rotation) for each lower extremity.
Baseline (one time assessment)
International Consensus on Incontinence Questionnaire (ICIQ-FLUTS Long Form)
a questionnaire that evaluates female lower urinary tract symptoms and quality of life in clinical practice and research. This questionnaire has been found to be valid, reliable, and responsive. The time required to complete this questionnaire is 4-5 minutes. This scale is 0-48 where all subscale scores are added and higher scores indicate greater impact of individual symptoms for the patient.
Baseline (one time assessment)
Patient Reported Outcome Measure Information System (PROMIS)
PROMIS Anxiety- CAT that focuses on fear (fearfulness, panic), anxious misery (worry, dread), hyperarousal (tension, nervousness, restlessness), and somatic symptoms related to arousal (racing heart, dizziness). The scale is between 8 and 40 raw score and is converted into a t score metric and a higher score indicates greater levels of anxiety. A score of 50 represents the average and a standard deviation (SD) of 10. PROMIS Depression- CAT that focuses on negative mood (sadness, guilt), views of self (self-criticism, worthlessness), and social cognition (loneliness, interpersonal alienation), as well as decreased positive affect and engagement (loss of interest, meaning, and purpose). The scale is between 8 and 40 raw score and is converted into a t score metric and a higher score indicates greater levels of depression. A score of 50 represents the average and a standard deviation (SD) of 10.
Baseline (one time assessment)
Study Arms (1)
Active Females
Active Females Ages 18-45
Eligibility Criteria
18-45 year old females who are active as described by the WHO.
You may qualify if:
- Age range 18-45 years
- Female gender
- Patients can either have no pelvic floor symptoms, current pelvic floor dysfunction (relaxing or nonrelaxing), or current musculoskeletal pain.
- Participants must be physically active as defined by the World Health Organization (WHO) as performing 150-300 minutes of moderate-intensity aerobic physical activity or at least 75-150 minutes of vigorous-intensity aerobic physical activity; or an equivalent combination of moderate- and vigorous-intensity activity throughout the week.
You may not qualify if:
- Pregnancy
- Gynecological or Obstetric Surgery within 6 months
- Active infection (including Sexually Transmitted Infection, Pelvic, Urinary Tract Infection (UTI), Yeast)
- Cancer
- Inflammatory Disease
- Connective Tissue Disease
- Or have been instructed by a Healthcare provider to not participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
George Fox University Medical Sciences Building
Newberg, Oregon, 97132, United States
Related Publications (9)
Beisecker L, Harrison P, Josephson M, DeFreese JD. Depression, anxiety and stress among female student-athletes: a systematic review and meta-analysis. Br J Sports Med. 2024 Mar 8;58(5):278-285. doi: 10.1136/bjsports-2023-107328.
PMID: 38233087BACKGROUNDVrijens D, Berghmans B, Nieman F, van Os J, van Koeveringe G, Leue C. Prevalence of anxiety and depressive symptoms and their association with pelvic floor dysfunctions-A cross sectional cohort study at a Pelvic Care Centre. Neurourol Urodyn. 2017 Sep;36(7):1816-1823. doi: 10.1002/nau.23186. Epub 2017 Feb 21.
PMID: 28220586BACKGROUNDSheikhhoseini R, Arab AM. Dry Needling in myofascial tracks in Non-Relaxing Pelvic Floor Dysfunction: A case study. J Bodyw Mov Ther. 2018 Apr;22(2):337-340. doi: 10.1016/j.jbmt.2017.09.016. Epub 2017 Sep 25.
PMID: 29861229BACKGROUNDLouis-Charles K, Biggie K, Wolfinbarger A, Wilcox B, Kienstra CM. Pelvic Floor Dysfunction in the Female Athlete. Curr Sports Med Rep. 2019 Feb;18(2):49-52. doi: 10.1249/JSR.0000000000000563.
PMID: 30730341BACKGROUNDFaubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012 Feb;87(2):187-93. doi: 10.1016/j.mayocp.2011.09.004.
PMID: 22305030BACKGROUNDAlmousa S, Bandin van Loon A. The prevalence of urinary incontinence in nulliparous adolescent and middle-aged women and the associated risk factors: A systematic review. Maturitas. 2018 Jan;107:78-83. doi: 10.1016/j.maturitas.2017.10.003. Epub 2017 Oct 7.
PMID: 29169586BACKGROUNDde Mattos Lourenco TR, Matsuoka PK, Baracat EC, Haddad JM. Urinary incontinence in female athletes: a systematic review. Int Urogynecol J. 2018 Dec;29(12):1757-1763. doi: 10.1007/s00192-018-3629-z. Epub 2018 Mar 19.
PMID: 29552736BACKGROUNDSorrigueta-Hernandez A, Padilla-Fernandez BY, Marquez-Sanchez MT, Flores-Fraile MC, Flores-Fraile J, Moreno-Pascual C, Lorenzo-Gomez A, Garcia-Cenador MB, Lorenzo-Gomez MF. Benefits of Physiotherapy on Urinary Incontinence in High-Performance Female Athletes. Meta-Analysis. J Clin Med. 2020 Oct 10;9(10):3240. doi: 10.3390/jcm9103240.
PMID: 33050442BACKGROUNDFoster SN, Spitznagle TM, Tuttle LJ, Sutcliffe S, Steger-May K, Lowder JL, Meister MR, Ghetti C, Wang J, Mueller MJ, Harris-Hayes M. Hip and Pelvic Floor Muscle Strength in Women with and without Urgency and Frequency Predominant Lower Urinary Tract Symptoms. J Womens Health Phys Therap. 2021 Jul-Sep;45(3):126-134. doi: 10.1097/jwh.0000000000000209.
PMID: 34366727BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Physical Therapy
Study Record Dates
First Submitted
July 30, 2025
First Posted
August 13, 2025
Study Start
November 11, 2024
Primary Completion
February 24, 2025
Study Completion
February 24, 2025
Last Updated
August 13, 2025
Record last verified: 2025-08